Pseudohypoxia: Difference between revisions
Content deleted Content added
No edit summary |
Rathfelder (talk | contribs) removed Category:Medical research; added Category:Medical signs using HotCat |
||
| Line 13: | Line 13: | ||
[[Category:Biology]] |
[[Category:Biology]] |
||
[[Category:Medical |
[[Category:Medical signs]] |
||
[[Category:Geriatrics]] |
[[Category:Geriatrics]] |
||
Revision as of 19:11, 4 September 2018
Pseudohypoxia refers to increased cytosolic ratio of free NAD to NADH in cells, caused by hyperglycemia.[1] Research has shown that declining levels of NAD+ during aging cause pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the aging process.[2] It is expected that human NAD trials will begin in 2014.[3]
Pseudohypoxia is a feature commonly noted in poorly-controlled diabetes.[1]
See also
- Hypoxia (medical)
- Hypoxia (disambiguation) - list under Hypoxia (medical) e.g Intrauterine hypoxia
References
 | This article about a disease, disorder, or medical condition is a stub. You can help Wikipedia by expanding it. |